Ctc Bio, Incorporation. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ctc Bio, Incorporation. with three other
companies in this sector in KOREA (SOUTH) :
Samil Pharmaceutical Co., Ltd.
sales of 121.11 billion Korean Won [US$110.33 million]
CKD Bio Corp
(137.18 billion Korean Won [US$124.97 million]
of which 100%
was Pharmaceutical Manufacturing), and
Kolon Life Science Incorporation
(148.54 billion Korean Won [US$135.32 million]
of which 98%
Ctc Bio, Incorporation. reported sales of 136.12 billion Korean Won (US$124.01 million)
December of 2019.
decrease of 1.6%
versus 2018, when the company's sales were 138.40 billion Korean Won .
Contributing to the drop in overall sales was the 13.5% decline
in Hay, from 36.11 billion Korean Won to 31.25 billion Korean Won .
However, these declines were partially offset by the increase in sales of
Animal Medication (up 5.8% to 108.30 billion Korean Won )
Human Medication (up 66.2% to 4.53 billion Korean Won )